Table 5:
Upconversion phosphor-based lateral flow assays
| Analyte | LFA format | Limit of Detection | Applied range | Analysis time | References |
|---|---|---|---|---|---|
| hCG | sandwich | 100 pg/mL | 0 – 10 ng/mL | 30 min | 92 |
| cTn1 | sandwich | 30 ng/L | 30 – 10,000 ng/L | 45 min | 104 |
| cTn1 | sandwich | 41 ng/L | 1 – 100,000 ng/L | N/A | 68 |
| PSA | sandwich | 556 ng/L | 1 – 100,000 ng/L | N/A | 68 |
| PSA | sandwich | 89 pg/mL | 0.01 – 100 ng/mL | 30 min | 103 |
| Ephrin type-A receptor 2 | sandwich | 400 pg/mL | 0.01 – 100 ng/mL | 30 min | 103 |
| N-terminal fragment of B-type natriuretic peptide precursor | sandwich | 116 ng/L | 50 – 35,000 ng/L | 20 min | 97 |
| Hepatitis B virus surface antigen | sandwich | 0.1 IU/mL | 0.01 – 12.8 IU/mL | 30 min | 105 |
| Hepatitis B virus surface antigen | sandwich | 20 mIU/mL | 20 – 900 mIU/mL | 10 min | 106 |
| IL-10 | sandwich | 30 pg/mL | 0 – 30,000 pg/mL | 40 min | 107 |
| Francisella tularensis | sandwich | 104 CFU/mL | 103 – 109 CFU/mL | 15 min | 108 |
| Schistosoma Circulating Anodic Antigen | sandwich | 0.5 pg/mL | 0.5 – 500 pg/mL | 1.5 – 2 hrs | 109 |
| Brain natriuretic peptide | sandwich | 5 pg/mL | 0 – 100 pg/mL | 20 min | 110 |
| Suppression of tumorigenicity 2 | sandwich | 1 ng/mL | 0 – 25 ng/mL | 20 min | 110 |